Skip to content Back to top
 

FOI 2025/1341

Reference FOI 2025/1341
Description National Institute of Clinical Excellence, Technology Appraisal (NICE TA) approved drugs
Date Requested 20/08/2025
Date Replied 03/09/2025
Category Medicines Optimisation

1. I would like details of how many National Institute of Clinical Excellence, Technology Appraisal (NICE TA) approved drugs have NOT been incorporated into local formulary’s/funded and what are the names of these drugs.
2. How many NICE TA approved drugs HAVE been incorporated into local formulary’s/funded and what the names of those drugs and when they were incorporated/available to prescribe in Greater Manchester.
Please provide all the above information for the last 5 years.

1. The GM ICB has committed to providing access to all NICE TA approved drugs. There are no drugs with a positive NICE TA which the ICB has decided not to add to formulary. Where there are medicines with a NICE TA that are yet to be added to the formulary, these will be included once the GM ICB’s governance process is complete. Please see minutes of meetings and decision summaries from the relevant groups: GMMMG and Subgroup Decision Summaries – GMMMG
2. All NICE TAs are included in formulary which is open access from here: Greater Manchester Formulary

Return to FOI Requests

Launch Recite Me assistive technology